These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.
As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?
A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.
The signatories of this Joint Statement are a group of health professional societies, non-profit organizations, advocates, policymakers and citizens. We hold the strong position that the global fight against Covid–19 will be won only if all stakeholders play their part. Therefore, we urge all global diagnostics, pharmaceutical and vaccine companies, including Gilead, to meet the following recommendations to ensure that all of humanity will have people’s vaccines, people’s medicines and people’s diagnostics.
While scientists are racing against time to develop a vaccine for COVID-19, other types of treatment are being tried out on the infected patients to battle against the coronavirus. This includes traditional Chinese Medicine (TCM). In China, medical doctors have said to combine TCM and Western medicine as part of COVID-19 treatment for its patients. We asked experts to comment about its effectiveness in treating COVID-19 patients.
While there is a considerable amount of general information out there about the spread of COVID-19, very little is targeted at people who may be immunosuppressed, including people living with HIV. We speak to Dr Tommy Tong, Immunologist and Senior Lecturer at the Department of Biological Science, Sunway University to learn about the risks of infection and use of HIV antiretroviral drugs to treat COVID-19.
As of today, the COVID-19 outbreak has soared past 1.5 million cases across 213 countries, with over 92,000 deaths. What do we know so far from testing for the novel coronavirus to available treatments? We speak to Dr Vinod RMT Balasubramaniam, Microbiologist & Senior Lecturer at Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia to learn more.
The World Health Organization (WHO) has called on countries to ‘test, test, test’ for COVID-19. We speak to Associate Prof. Dr. Chan Yoke Fun, a virologist from the Department of Medical Microbiology, Faculty of Medicine, University of Malaya to explain how COVID-19 diagnostic test kits work.